Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Prognostic Value of Microvascular Function in Takotsubo Syndrome: a Pooled Analysis of Individual Patient Data.

Prognostic Value of Microvascular Function in Takotsubo Syndrome: a Pooled Analysis of Individual Patient Data. JACC. Cardiovascular interventions Eerdekens, R., El Farissi, M., De Maria, G. L., Shetrit, A., Sykes, R., Ekenbäck, C., Persson, J., Spaak, J., Couch, L. S., Alfonso, F., Rivero, F., Gonzalo, N., Escaned, J., Núñez Gil, I. J., Cruz, O. V., Shamir, R. A., Freund, O., Vanderheyden, M., Belmonte, M., Barbato, E., Tonino, P. A., Banning, A., Solberg, O. G., Berry, C., Fearon, W. F., Zimmermann, F. M. 2025

Abstract

Coronary microvascular dysfunction appears to play a major role in the pathogenesis of Takotsubo Syndrome (TTS). However, the prognostic value of microvascular function measured in the acute phase of TTS is unclear.In a collaborative, pooled analysis of individual patient data from nine prospective TTS cohorts, invasive assessment of coronary microvascular function was performed, including the index of microcirculatory resistance (IMR), coronary flow reserve (CFR), and microvascular resistance reserve (MRR). The primary endpoint was all-cause mortality. Secondary endpoints included major adverse cardiac and cerebrovascular events (MACCE) defined as the composite of all-cause death, recurrence of TTS, stroke, transient ischemic attack, or myocardial infarction.One hundred and sixty six patients with TTS were included, in whom 130 (78%) had the typical (apical) TTS variant and 36 (22%) an atypical variant. During a median follow-up of 20.6 [4.3 - 60.0] months, all-cause mortality occurred in 17 patients (10.2%) and MACCE in 29 patients (17.5%). IMR, CFR, and MRR were associated with all-cause mortality. After adjustment for baseline differences, IMR was the only independent predictor of both all-cause mortality (aHR 3.9; 95% CI: 1.39-10.88, P = 0.010; c-statistic 0.817 (95% CI: 0.711-0.923)) and MACCE (aHR 2.6; 95% CI: 1.17-5.67; P = 0.018; c-statistic 0.719 (95% CI: 0.612-0.826)).In this pooled analysis of individual patient data from nine prospective TTS cohorts, microvascular dysfunction measured in the acute phase, was associated with all-cause mortality. In particular, an elevated microvascular resistance, as assessed by IMR, was the only independent predictor of both mortality and MACCE.

View details for DOI 10.1016/j.jcin.2025.05.028

View details for PubMedID 40415182